Transforming Discovery of Therapeutics and Materials February 24, 2022 Fourth Quarter and Full-Year 2021 Supplemental Slides Cautionary Note and Disclaimer This presentation contains certain "forward-looking statements" within the meaning of the U.S. Private Securities Litigation Reform Act of 1995 that involve substantial risks and uncertainties. All statements, other than statements of historical fact, contained in this presentation, including, without limitation, statements regarding the potential advant ...

Schrodinger, Inc. (NASDAQ:SDGR) Q4 2021 Earnings Conference Call February 24, 2022 5:00 PM ET Company Participants Ramy Farid - CEO, President & Director Jaren Madden - SVP, IR & Corporate Communications Joel Lebowitz - CFO & EVP Karen Akinsanya - EVP, Chief Biomedical Scientist and Head, Discovery R&D Conference Call Participants Do Kim - Piper Sandler Vikram Purohit - Morgan Stanley Andrew Tsai - Jefferies Lucas Baranowski - Craig-Hallum Capital Gary Nachman - BMO Capital Markets Derik De Bruin - Bank of ...

Schrödinger, Inc. (NASDAQ:SDGR) Q3 Earnings Conference Call November 10, 2021 4:30 PM ET Company Participants Ramy Farid – CEO Joel Lebowitz – CFO Karen Akinsanya – Executive Vice President Jaren Madden – Senior Vice President, IR Conference Call Participants Michael Ryskin – Bank of America Gary Nashman – BMO Capital Markets Matt Hewitt – Craig-Hallum Capital Group Gora Gabarachu – BMO Capital Michael Yee – Jefferies Operator Thank you for standing by. Welcome to Schrodinger's conference call to review the ...

Schrödinger, Inc. (CSIQ) Q2 2021 Earnings Conference Call August 12, 2021 8:30 AM ET Company Participants Ramy Farid – President and CEO Tracy Lessor – Executive Director of Corporate Communications Karen Akinsanya – Executive Vice President, Chief Biomedical Scientists, and Head of Discovery R&D Joel Lebowitz – Executive Vice President and CFO Conference Call Participants Michael Yee – Jefferies Michael Ryskin – Bank of America Gary Nashman – BMO Capital Markets David Lebowitz – Morgan Stanley Matt Hewitt ...

Schrödinger, Inc. (NASDAQ:SDGR) Q1 2021 Earnings Conference Call May 11, 2021 8:30 AM ET Company Participants Jaren Madden - Senior Vice President, Investor Relations and Corporate Communications Ramy Farid - President and CEO Karen Akinsanya - Executive Vice President, CBS and Head, Discovery R&D Joel Lebowitz - Executive Vice President and CFO Conference Call Participants Michael Yee - Jefferies Michael Ryskin - Bank of America Do Kim - BMO Capital Markets David Lebowitz - Morgan Stanley Operator Thank yo ...

SCHRÖDINGER. Transforming Discovery of Therapeutics and Materials March 23, 2021 Cautionary Note and Disclaimer This presentation contains certain "forward-looking statements" within the meaning of the U.S. Private Securities Litigation Reform Act of 1995 that involve substantial risks and uncertainties. All statements, other than statements of historical fact, contained in this presentation, including, without limitation, statements regarding the potential advantages of our physics-based computational plat ...

Start Time: 08:30 January 1, 0000 9:16 AM ET Schrödinger, Inc. (NASDAQ:SDGR) Q4 2020 Earnings Conference Call March 04, 2021, 08:30 AM ET Company Participants Ramy Farid - President and CEO Joel Lebowitz - EVP and CFO Karen Akinsanya - EVP, Chief Biomedical Scientist, Head of Discovery R&D Jaren Madden - SVP, IR and Corporate Communications Conference Call Participants Michael Yee - Jefferies Do Kim - BMO Capital Markets Michael Ryskin - Bank of America Merrill Lynch Operator Thank you for standing by, and ...

Start Time: 08:30 January 1, 0000 9:01 AM ET Schrödinger, Inc. (NASDAQ:SDGR) Q3 2020 Earnings Conference Call November 12, 2020, 08:30 AM ET Company Participants Ramy Farid - President and CEO Karen Akinsanya - EVP, Chief Biomedical Scientist, Head of Discovery R&D Joel Lebowitz - EVP and CFO Conference Call Participants Do Kim - BMO Capital Markets Michael Yee - Jefferies Michael Ryskin - Bank of America Merrill Lynch Operator Ladies and gentlemen, good morning, and welcome to the Schrödinger Third Quarter ...

Schrödinger, Inc. (NASDAQ:SDGR) Q2 2020 Earnings Conference Call August 10, 2020 8:30 AM ET Company Participants Ramy Farid - President and CEO Karen Akinsanya - EVP, Chief Biomedical Scientist, Head of Discovery R&D Joel Lebowitz - EVP and CFO Conference Call Participants David Lebowitz - Morgan Stanley Do Kim - BMO Capital Markets Mike Ryskin - Bank of America Operator Good morning and welcome to the Schrödinger Second Quarter 2020 Earnings Conference Call. At this time, all participant lines are in a lis ...

SCHRÖDINGER. Transforming Discovery of Therapeutics and Materials Cautionary Note and Disclaimer This presentation contains certain "forward-looking statements" within the meaning of the U.S. Private Securities Litigation Reform Act of 1995 that involve substantial risks and uncertainties. All statements, other than statements of historical fact, contained in this presentation, including, without limitation, statements regarding the potential advantages of our physics-based computational platform, our strat ...